From: Correlation of trans fatty acids with the severity of coronary artery disease lesions
Controls n = 120 | CAD patients n = 111 | |
---|---|---|
Inflammatory markers (plasma) | ||
TNF-α pg/mL | 3.22 ± 3.27 | 7.40 ± 3.38** |
IL-6 pg/mL | 4.39 ± 1.50 | 7.12 ± 3.90** |
hs-CRP (mg/L) | 1.22 ± 0.95 | 3.03 ± 2.26** |
Antioxidative parameters | ||
FRAP μMol/L (plasma) | 905.99 ± 216.76 | 842.00 ± 171.15* |
Thiol SH μMol/L (plasma) | 308.70 ± 55.04 | 172.13 ± 65.55** |
Catalase (U/g HB) (RBCs) | 73.83 ± 59.82 | 299.55 ± 11.00** |
GPX (U/g HB) (RBCs) | 41.51 ± 9.70 | 32.55 ± 5.97** |
SOD U/g HB (RBCs) | 2103.26 ± 286.12 | 1531.66 ± 424.55** |
Lipid peroxidation markers (RBCs) | ||
MDA (nM/gP) (RBCs) | 12.80 ± 3.42 | 18.01 ± 5.16** |
Conjugated diene (nM hydroperoxides / gP) (RBCs) | 111.10 ± 53.46 | 155.99 ± 80.07** |